Dr. Lawrence Panasci
Professor - Department of Medicine, Division of Experimental Medicine
1. DNA repair inhibitors vis-a-vis cancer drug resistance.
2. Combi-molecules of c-abl inhibitors with alkylating agents in CLL.
3. P13K inhibitors in the treatment of CLL including their mechanism of action.
4. Probing the effect and molecular mechanism of combined inhibition of the ATR and PARP pathways in irinotecan drug resistance in colon cancer models.